[go: up one dir, main page]

TR200003569T2 - 5-HT reseptörlerine karşı ilgileri olan N-benzodioksanilmetil-1-piperidil-metilamin bileşikleri. - Google Patents

5-HT reseptörlerine karşı ilgileri olan N-benzodioksanilmetil-1-piperidil-metilamin bileşikleri.

Info

Publication number
TR200003569T2
TR200003569T2 TR2000/03569T TR200003569T TR200003569T2 TR 200003569 T2 TR200003569 T2 TR 200003569T2 TR 2000/03569 T TR2000/03569 T TR 2000/03569T TR 200003569 T TR200003569 T TR 200003569T TR 200003569 T2 TR200003569 T2 TR 200003569T2
Authority
TR
Turkey
Prior art keywords
disease
disorders
benzodioxanylmethyl
piperidyl
receptors
Prior art date
Application number
TR2000/03569T
Other languages
English (en)
Inventor
Wishart Neil
Martin Birch Alan
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of TR200003569T2 publication Critical patent/TR200003569T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

R'nin H'yi ya da F'yi temsil ettigi farmasötik olarak uygun olan tuzlari da dahil olmak üzere formül (I)'in bilesikleri, bunlarin hazirlanmasi ve depresyon, asiri heyecan, pisikozlar, Parkinson hastaligi, sismanlik, hipertansiyon, Tourette sendromu, cinsel iktidarsizlik, uyusturucu bagimliligi, uyusturucu kullanimi, kavrama bozukluklari, Alzheimer hastaligi, yasliliga bagli bunama, obsesif kompulsif davranis, panik atak, beslenme bozukluklari, anoreksia, kardiyovasküler ve serebrovasküler rahatsizliklar, migren, insüline bagimli olmayan seker hastaligi, hiperglisemi, kabizlik, aritmi, nöroendokrin sistem bozukluklari, prostatik hipertrofi, uyusturuculardan kaynaklanan ekstrapiramidal semptomlar ya da spastikligin tedavisindeki kullanimlari açiklanmaktadir.
TR2000/03569T 1998-06-03 1999-05-26 5-HT reseptörlerine karşı ilgileri olan N-benzodioksanilmetil-1-piperidil-metilamin bileşikleri. TR200003569T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9811879.7A GB9811879D0 (en) 1998-06-03 1998-06-03 Therapeutic agents

Publications (1)

Publication Number Publication Date
TR200003569T2 true TR200003569T2 (tr) 2001-04-20

Family

ID=10833098

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03569T TR200003569T2 (tr) 1998-06-03 1999-05-26 5-HT reseptörlerine karşı ilgileri olan N-benzodioksanilmetil-1-piperidil-metilamin bileşikleri.

Country Status (20)

Country Link
EP (1) EP1087964A1 (tr)
JP (1) JP2002517392A (tr)
KR (1) KR20010052526A (tr)
CN (1) CN1304408A (tr)
AR (1) AR018622A1 (tr)
AU (1) AU4369599A (tr)
BG (1) BG104988A (tr)
BR (1) BR9910927A (tr)
CA (1) CA2333756A1 (tr)
CO (1) CO5021190A1 (tr)
GB (1) GB9811879D0 (tr)
HR (1) HRP20010005A2 (tr)
HU (1) HUP0102233A2 (tr)
ID (1) ID27067A (tr)
IL (1) IL139552A0 (tr)
NO (1) NO20006041L (tr)
PL (1) PL344594A1 (tr)
SK (1) SK17602000A3 (tr)
TR (1) TR200003569T2 (tr)
WO (1) WO1999062902A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915616D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
GB0007376D0 (en) * 2000-03-28 2000-05-17 Knoll Ag Therapeutic agents
JP2003532676A (ja) * 2000-05-12 2003-11-05 ソルベイ・フアーマシユーチカルズ・ベー・ブイ ＣＮＳ障害を治療するための組合せられたドーパミンＤ２、５−ＨＴ１Ａおよびαアドレノレセプターアゴニスト作用、を有する化合物の使用
DK1283838T3 (da) * 2000-05-12 2004-03-22 Solvay Pharm Bv Piperazin- og piperidinforbindelser
AR052674A1 (es) 2005-02-17 2007-03-28 Wyeth Corp Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilcondensados

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2701479B1 (fr) * 1993-02-11 1995-05-12 Pf Medicament Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
GB9514380D0 (en) * 1995-07-13 1995-09-13 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
GB9811879D0 (en) 1998-07-29
AU4369599A (en) 1999-12-20
NO20006041D0 (no) 2000-11-29
BR9910927A (pt) 2001-02-20
ID27067A (id) 2001-02-22
JP2002517392A (ja) 2002-06-18
CO5021190A1 (es) 2001-03-27
NO20006041L (no) 2000-11-29
EP1087964A1 (en) 2001-04-04
IL139552A0 (en) 2002-02-10
CA2333756A1 (en) 1999-12-09
SK17602000A3 (sk) 2001-08-06
PL344594A1 (en) 2001-11-05
HUP0102233A2 (hu) 2002-05-29
BG104988A (bg) 2001-11-30
WO1999062902A1 (en) 1999-12-09
AR018622A1 (es) 2001-11-28
CN1304408A (zh) 2001-07-18
KR20010052526A (ko) 2001-06-25
HRP20010005A2 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
TW200503705A (en) 3-amino chroman and 2-amino tetralin derivatives
MXPA05013711A (es) Derivados 3-sustituidos de 5,6-diaril-pirazin-2-carboxi-amida y -2-sulfonamida, como moduladores de cb1.
NO20073051L (no) Tetralin- og indanderivater og deres anvedelse
BG108495A (en) 5-ht receptor ligands and uses thereof
BG108683A (en) Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
AP1649A (en) Triamide-substituted heterobicyclic compounds.
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
YU63202A (sh) Derivati 2-okso-1-pirolidina, postupci za njihovo dobijanje i njihove upotrebe
WO2002036596A3 (en) CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES
WO2005080343A3 (en) 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
NZ544591A (en) Pyrrolodihydroisoquinolines as PDE10 inhibitors
GB0504828D0 (en) Therapeutic agents
AP2004003103A0 (en) Controlled synthesis of ziprasidone and compositions thereof
NO20061845L (no) Fenyl-piperazinderivater som modulatorer for muskarine reseptorer
DK1551803T3 (da) Azabicycloderivater som muskarine receptorantagonister
EA200600071A1 (ru) Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором
AU1884595A (en) Novel acyclic and cyclic amides as neurotransmitter release enhancers
DE502004011551D1 (de) 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen
MY138826A (en) 2,7-substituted indoles
TR200003569T2 (tr) 5-HT reseptörlerine karşı ilgileri olan N-benzodioksanilmetil-1-piperidil-metilamin bileşikleri.
DK0700384T3 (da) fremgangsmåde til fremstilling og opløsning af 2-phenyl-3-aminopiperidin
DE60206762D1 (de) Hexahydroazepino[4,5-g]indole und -indoline als 5-ht-rezeptor-liganden
ATE282605T1 (de) 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
NO20051663L (no) Fremgangsmater for behandling av neurodegenerasjon